- Home
- SNX vs INM Comparison
SNX vs INM Comparison
Compare SNX & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SNX | INM |
|---|---|---|
| Founded | 1980 | 1981 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.4B | 7.1M |
| IPO Year | 2003 | 2020 |
Fundamental Metrics
Financial Performance| Metric | SNX | INM |
|---|---|---|
| Price | $271.55 | $1.32 |
| Analyst Decision | Buy | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $339.64 | N/A |
| AVG Volume (30 Days) | ★ 856.5K | 52.7K |
| Earning Date | 09-24-2026 | 11-05-2026 |
| Dividend Yield | ★ 0.75% | N/A |
| EPS Growth | 25.16 | ★ 62.68 |
| EPS | ★ 8.19 | N/A |
| Revenue | ★ $20,053,764,000.00 | $4,942,633.00 |
| Revenue This Year | $28.82 | N/A |
| Revenue Next Year | $9.82 | $26.00 |
| P/E Ratio | $31.68 | ★ N/A |
| Revenue Growth | ★ 17.65 | 7.50 |
| 52 Week Low | $142.22 | $0.58 |
| 52 Week High | $298.77 | $2.50 |
Technical Indicators
Market Signals| Indicator | SNX | INM |
|---|---|---|
| Relative Strength Index (RSI) | 48.25 | 44.37 |
| Support Level | $241.67 | $1.25 |
| Resistance Level | $265.45 | $1.40 |
| Average True Range (ATR) | 8.95 | 0.06 |
| MACD | -1.64 | 0.01 |
| Stochastic Oscillator | 29.39 | 35.28 |
Price Performance
Historical ComparisonAbout SNX TD SYNNEX Corporation
TD Synnex Corp is a distributor and solutions aggregator for the IT ecosystem. The company aggregates and distributes IT hardware, software, and systems including personal computing devices and peripherals, mobile phones and accessories, printers, server and data center infrastructure, hybrid cloud, security, networking, communications and storage solutions, and system components. Its geographical segments include the Americas, Europe, and APJ.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a pharmaceutical company developing a pipeline of disease-modifying small molecule drug candidates targeting CB1 and CB2 receptors. The company's pipeline consists of three separate programs in the treatment of Alzheimer's, ocular and dermatological indications.